Skip to main content

Table 1 Clinical characteristics of patients with GDM and patients with GDM with subsequently developed PE (GDM/PE)

From: Screening of differentially expressed proteins from syncytiotrophoblast for severe early-onset preeclampsia in women with gestational diabetes mellitus using tandem mass tag quantitative proteomics

 

GDM

GDM/PE

P value

Sample size (n)

9

9

 

Maternal age (years)

32.67 ± 5.12

30.22 ± 3.90

0.107

Parity

0.44 ± 0.53

0.33 ± 0.47

0.681

Pregnancy BMI at 12 week (kg/m2)

25.76 ± 2.56

25.93 ± 2.14

0.824

Gestation age at delivery (wk)

38.49 ± 0.98

33.97 ± 1.05

< 0.001*

Gestation age at 75-g OGTT (wk)

24.70 ± 040

24.81 ± 0.49

1.100

OGTT 0 h glucose (mmol/L)

5.46 ± 0.64

5.31 ± 0.27

0.533

OGTT 2 h glucose (mmol/L)

7.36 ± 1.12

8.43 ± 1.39

0.027*

Insulin (mU/L)

11.73 ± 1.79

15.17 ± 3.09

0.046*

Maximum SBP (mmHg)

131.33 ± 5.70

186.44 ± 11.59

< 0.001*

Maximum DBP (mmHg)

85.22 ± 4.58

121.89 ± 9.46

< 0.001*

Proteinuria (g/24 h)

0.01 ± 0.01

5.56 ± 1.65

< 0.001*

  1. *P < 0.05
Back to article page

BMC Pregnancy and Childbirth

ISSN: 1471-2393

Contact us